Integrated Security buys oral insulin technology patent

By Ted A. Knutson

Washington, Feb. 17 - Integrated Security Technologies, Inc. said Friday it agreed to purchase U.S. patent application 60/718716, including related intellectual property, from Hadasit Medical Services and Development Ltd. for technology to allow the administration of insulin orally.

Hadasit also agreed to provide consulting services to Integrated for $200,000 so that clinical trials, including a full report, may be conducted.

Integrated also agreed to secure proper conditions for the future development of the patent application product and to sell at least $1 million in Integrated common stock to fund the development.

Integrated is a Vancouver, B.C.-based biotechnology company.

The announcement was made in an 8-K filing with the Securities and Exchange Commission.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.